Sara Vieira‐Silva

Gut dysbiosis is linked to severe steatosis and enhances its diagnostic performance in MASLD

Individual-network based predictions of microbial interaction signatures for response to biological therapies in IBD patients

Dietary convergence induces individual responses in faecal microbiome composition

Microbiome confounders and quantitative profiling challengepredicted microbial targets in colorectal cancer development

Rigorous Donor Selection for Fecal Microbiota Transplantation in Active Ulcerative Colitis: Key Lessons From a Randomized Controlled Trial Halted for Futility

Differential contributions of the gut microbiota and metabolome to pathomechanisms in ulcerative colitis: an <i>in vitro</i> analysis

Dysbiosis and Associated Stool Features Improve Prediction of Response to Biological Therapy in Inflammatory Bowel Disease

Evidence of a causal and modifiable relationship between kidney function and circulating trimethylamine N-oxide

Gut microbiome composition is associated with long-term disability worsening in multiple sclerosis

Community Types of the Human Gut Virome are Associated with Endoscopic Outcome in Ulcerative Colitis

Oral dydrogesterone versus micronized vaginal progesterone for luteal phase support: a double-blind crossover study investigating pharmacokinetics and impact on the endometrium

Systematic optimization of fermentation conditions for in vitro fermentations with fecal inocula

Microbiome and metabolome features of the cardiometabolic disease spectrum

Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism

The virota and its transkingdom interactions in the healthy infant gut

Fat and not sugar as the determining factor for gut microbiota changes, obesity, and related metabolic disorders in mice

Large-scale association analyses identify host factors influencing human gut microbiome composition

Novel insights into the genetically obese (ob/ob) and diabetic (db/db) mice: two sides of the same coin

Combinatorial, additive and dose-dependent drug–microbiome associations

<i>Dysosmobacter welbionis</i> is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice

Human and preclinical studies of the host–gut microbiome co-metabolite hippurate as a marker and mediator of metabolic health

Variation and transmission of the human gut microbiota across multiple familial generations

Exploring the relationship between the gut microbiome and mental health outcomes in a posttraumatic stress disorder cohort relative to trauma-exposed controls

Benchmarking microbiome transformations favors experimental quantitative approaches to address compositionality and sampling depth biases

Statin therapy is associated with lower prevalence of gut microbiota dysbiosis

Genome-wide associations of human gut microbiome variation and implications for causal inference analyses

Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology

A synthesis of bacterial and archaeal phenotypic trait data

Review article: how the intestinal microbiota may reflect disease activity and influence therapeutic outcome in inflammatory bowel disease

The reproductive microbiome – clinical practice recommendations for fertility specialists